Kintara Therapeutics, Inc.
KTRA
NASDAQ
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -22.71% | 722.67% | 257.41% | -85.93% | -70.45% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 99.04% | -33.12% | -45.15% | -14.09% | -19.61% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 4.59% | -- | -- | -- | -- |
Total Current Assets | -18.16% | 469.56% | 51.47% | -76.06% | -45.64% |
|
|||||
Total Current Assets | -18.16% | 469.56% | 51.47% | -76.06% | -45.64% |
Net Property, Plant & Equipment | -2.46% | -1.14% | 0.72% | -2.12% | -2.07% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -16.71% | 295.01% | 27.62% | -62.88% | -40.96% |
|
|||||
Total Accounts Payable | 77.55% | -27.82% | -42.56% | 7.69% | 6.67% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -46.94% | -33.78% | -56.21% | 13.42% | 65.56% |
Total Other Current Liabilities | -46.94% | -33.78% | -56.21% | 13.42% | 65.56% |
Total Current Liabilities | 68.46% | -28.29% | -43.94% | 8.24% | 10.47% |
|
|||||
Total Current Liabilities | 68.46% | -28.29% | -43.94% | 8.24% | 10.47% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 1.64% | 2.23% | 7.19% | 0.60% | 1.22% |
Total Liabilities | 60.43% | -25.62% | -41.51% | 7.85% | 9.95% |
|
|||||
Common Stock & APIC | 0.11% | 5.58% | 2.29% | 0.29% | 0.20% |
Retained Earnings | -1.48% | -1.29% | -0.66% | -2.07% | -2.25% |
Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Common Equity | -50.00% | 58.43% | 17.56% | -27.44% | -44.54% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Preferred Stock Convertible | 0.00% | 0.00% | -3.45% | -0.36% | 0.00% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00% | 0.00% | -3.36% | -0.35% | 0.00% |
|
|||||
Total Common Equity | -50.00% | 58.43% | 17.56% | -27.44% | -44.54% |
Total Preferred Equity | 0.00% | 0.00% | -3.36% | -0.35% | 0.00% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -36.56% | 3,710.98% | 91.91% | -377.15% | -80.69% |
|